Clinical Trials Directory

Trials / Completed

CompletedNCT01007409

A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Randomized, Open-labeled, Single Dosing Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Boryung Pharmaceutical Co., Ltd · Industry
Sex
Male
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGFimasartanPeriod 1: administration of fimasartan 240mg at 9:00am, 30 minutes after the breakfast Period 2: administration of fimasartan 240mg at 9:00am, without the breakfast
DRUGFimasartanPeriod 1: administration of fimasartan 240mg at 9:00am, without the breakfast Period 2: administration of fimasartan 240mg at 9:00am, 30 minutes after the breakfast

Timeline

Start date
2009-10-01
Primary completion
2009-11-01
First posted
2009-11-04
Last updated
2009-12-24

Source: ClinicalTrials.gov record NCT01007409. Inclusion in this directory is not an endorsement.